Company profile
ScripsAmerica, Inc.
OTC: SCRCQ · Healthcare · Medical - Distribution
#500 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 39
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), 3-yr revenue growth · ↓ growth stability, market scale
Methodology →Revenue TTM
$39.5M
Rev growth YoY (TTM)
+3510.5%
Net income (FY)
-$4.7M
Employees
21
as of 2026-08-29
Market cap
$14.1k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$30.9M$30.9M2014
Net income-$4.7M-$4.7M2014
Operating income-$3.8M-$3.8M2014
Total assets$5.6M$5.6M2014
Liabilities$9.2M$9.2M2014
Equity-$3.2M-$3.2M2014
Revenue trend
FY2010 – FY2014 · USD
FY10
FY11
FY12
FY13
FY14
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is ScripsAmerica, Inc.’s revenue?
ScripsAmerica, Inc. booked $30.9M in FY2014 revenue, growing 5448% year over year — faster than 99% of Healthcare companies we track, at a -15.3% net margin.
Peers · Healthcare
EyePoint Pharmaceuticals, Inc.58CVerastem, Inc.49DFoghorn Therapeutics Inc.47DBioSyent Inc.83B+STRATA Skin Sciences, Inc.52DYourWay Cannabis Brands Inc.——Neighbors
Passaic →Key facts
CEOBrian Ettinger
SectorHealthcare
IndustryMedical - Distribution
HeadquartersClifton, NJ
ExchangeOTC: SCRCQ
Employees21
IPO date2012-07-19
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.